Drugs / Creon IR
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02415959 | Mar → Jul 2015 | exocrine pancreatic insufficiency | Abbott | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Creon IR | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02415959 ↗ |
| Known as | Creon Immediate Release (IR) | “Creon Immediate Release (IR) in comparison to Creon® 25,000 Delayed Release/Gastro-Resistant (DR/GR)” NCT02415959 ↗ |